BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 34322605)

  • 1. The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.
    Manolea C; Capitanescu A; Borș R; Rugescu I; Bechir M; Mehedintu C; Varlas V
    Hum Reprod Open; 2021; 2021(3):hoab028. PubMed ID: 34322605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of contamination of semen, vaginal secretions, follicular fluid and ovarian medulla with SARS-CoV-2 in patients undergoing ART.
    Kteily K; Pening D; Diaz Vidal P; Devos M; Dechene J; Op de Beeck A; Botteaux A; Janssens S; Van den Abbeel E; Goldrat O; Delbaere A; Demeestere I
    Hum Reprod; 2022 Jan; 37(2):235-241. PubMed ID: 34741508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.
    Nelson SM; Ehnert S; Gromski PS; Child T; Trew G
    Hum Reprod Open; 2020; 2020(4):hoaa056. PubMed ID: 34056138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
    Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
    Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health.
    Vimercati L; Stefanizzi P; De Maria L; Caputi A; Cavone D; Quarato M; Gesualdo L; Lopalco PL; Migliore G; Sponselli S; Graziano G; Larocca AMV; Tafuri S
    Environ Res; 2021 Apr; 195():110793. PubMed ID: 33508260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.
    Hodgson D; Colton H; Hornsby H; Brown R; Mckenzie J; Bradley KL; James C; Lindsey BB; Birch S; Marsh L; Wood S; Bayley M; Dickson G; James DC; Nicklin MJH; Sayers JR; Zafred D; Rowland-Jones SL; Kudesia G; Kucharski A; ; Darton TC; de Silva TI; Collini PJ
    medRxiv; 2021 Jul; ():. PubMed ID: 34268521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.
    Alharbi SA; Almutairi AZ; Jan AA; Alkhalify AM
    Cureus; 2020 Sep; 12(9):e10285. PubMed ID: 33047077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal screening of high-risk neonates, parents, and staff at a neonatal intensive care unit during the SARS-CoV-2 pandemic.
    Cavicchiolo ME; Trevisanuto D; Lolli E; Mardegan V; Saieva AM; Franchin E; Plebani M; Donato D; Baraldi E
    Eur J Pediatr; 2020 Dec; 179(12):1949-1955. PubMed ID: 32767137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 in first trimester pregnancy: a cohort study.
    la Cour Freiesleben N; Egerup P; Hviid KVR; Severinsen ER; Kolte AM; Westergaard D; Fich Olsen L; Prætorius L; Zedeler A; Christiansen AH; Nielsen JR; Bang D; Berntsen S; Ollé-López J; Ingham A; Bello-Rodríguez J; Storm DM; Ethelberg-Findsen J; Hoffmann ER; Wilken-Jensen C; Jørgensen FS; Westh H; Jørgensen HL; Nielsen HS
    Hum Reprod; 2021 Jan; 36(1):40-47. PubMed ID: 33145598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study.
    Serra N; Andriolo M; Butera I; Mazzola G; Sergi CM; Fasciana TMA; Giammanco A; Gagliano MC; Cascio A; Di Carlo P
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
    Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
    J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave.
    Candoni A; Petruzzellis G; Sperotto A; Andreotti V; Giavarra M; Corvaja C; Minisini A; Comuzzi C; Tascini C; Fanin R; Fasola G
    PLoS One; 2022; 17(2):e0262784. PubMed ID: 35108300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
    Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome Coronavirus-2 Seropositivity in South-Central Uganda, During 2019 - 2021.
    Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
    Res Sq; 2021 Oct; ():. PubMed ID: 34704090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.